{"id":71,"date":"2023-07-26T12:15:46","date_gmt":"2023-07-26T12:15:46","guid":{"rendered":"https:\/\/geiselmed2.dartmouth.edu\/scd2\/?page_id=68"},"modified":"2023-09-08T22:11:35","modified_gmt":"2023-09-08T22:11:35","slug":"past-trainees","status":"publish","type":"page","link":"https:\/\/geiselmed.dartmouth.edu\/scd\/past-trainees\/","title":{"rendered":"Past Trainees"},"content":{"rendered":"

\"women<\/p>

Molly Barlow Anderson, PhD<\/h3>\n

PhD, University of Florida, 2020<\/p>\n

Research interests<\/b>
\nAfter earning my PhD in the spring of 2020, I began working under the mentorship of Dr. Catherine Stanger to investigate the use of digital interventions to improve health behaviors, and to leverage behavioral economics to better understand effective intervention components. Since completing my T32 training at Dartmouth, I have accepted a Senior Scientist position at Advocates for Human Potential, Inc. In this role, I conduct research to assess and evaluate substance use prevention and recovery programs.<\/p>\n<\/div><\/div>

<\/div>

\"man<\/p>

Steven F. Babbin, PhD<\/h3>\n

PhD in Experimental Psychology, University of Rhode Island, 2014<\/p>\n

Research interests<\/b>
\nDuring my T32 training at Dartmouth, I worked with Dr. Stanger and Dr. Budney on interventions for adolescent cannabis use disorders. After my T32, I entered the field of institutional research. I am currently a Senior Research Analyst at the Office of Institutional Research at Tufts University. My work primarily involves survey research projects, data analytics, and consultation for internal and external stakeholders. Topics of interest include student outcomes, enrollment, alumni, accreditation, and federal reporting.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Deepika Rao, PhD, MS, BPharm<\/h3>\n

PhD in Health Services Research in Pharmacy, University of Wisconsin-Madison, 2022<\/p>\n

Research interests<\/b><\/p>\n

Deepika Rao is an Assistant Professor in the Division of Health Outcomes at the College of Pharmacy at the University of Texas at Austin. Dr. Rao received her PhD in Health Services Research in Pharmacy (2022) from the University of Wisconsin-Madison along with a graduate minor in prevention and intervention science. She also holds a Master of Science in Pharmacy Administration (2018) from Duquesne University, Pittsburgh and a Bachelor of Pharmacy (2016) from the University of Mumbai, India. As part of the T32 postdoctoral fellowship at CTBH, Dr. Rao worked with Drs. Sarah Lord and Lisa Marsch on several research projects through the CTBH Dissemination and Implementation Core and CTN 0116.<\/span><\/p>\n

Dr. Rao's research is focused on the development and implementation of patient-centered interventions in the prevention and treatment of substance use and mental health disorders, especially focused on the role of pharmacists and in pharmacy settings. In her work, Dr. Rao utilizes community engaged research methods, dissemination and implementation sciences, and qualitative and mixed methodologies. Her recent work leverages the rich potential of digital technologies in the prevention and treatment of substance use disorders as well as the treatment and management of co-occurring conditions such as chronic pain, pregnancy, and mood disorders. Her research has been funded by the American Association of Psychiatric Pharmacists Foundation (previously CPNP), Sonderegger Research Center at UW-Madison, and a NIDA P30 pilot grant from CTBH.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Jacob Borodovsky, PhD<\/h3>\n

PhD, The Dartmouth Institute for Health Policy & Clinical Practice, 2018<\/p>\n

Research interests<\/b>
\nI am a Research Scientist and Epidemiologist at CTBH and the Department of Biomedical Data Science in the Dartmouth Geisel School of Medicine. I received my PhD from the Dartmouth Institute for Health Policy and Clinical Practice under the mentorship of Drs. Lisa Marsch, Alan Budney, and Emily Scherer. I completed my postdoctoral training at the Washington University School of Medicine in St. Louis under the mentorship of Drs. Richard Gruzca and Laura Bierut and was awarded an NRSA F32 fellowship by the National Institute on Alcohol Abuse and Alcoholism during this time. My research interests lie at the intersection of addiction, epidemiology, statistical methods, and policy. I enjoy thinking about and trying to answer questions such as, \u201cWhy do humans use drugs?\u201d \u201cWhat is the best way to measure drug use?\u201d and \u201cWhat happens to drug use behaviors when we try to modify them with population-level regulations and individual-level interventions?\"<\/p>\n<\/div><\/div>

<\/div>

\"man<\/p>

John Brand, PhD (Affiliated Trainee)<\/h3>\n

PhD in Experimental and Applied Psychology, Concordia University<\/p>\n

Research interests<\/b>
\nMy research studies the interface between the attention system of the human brain and childhood and adolescent health. I am particularly interested in the use of cognitive paradigms to isolate and understand the role that attention may play in public health issues, such as childhood obesity and youth tobacco use. During my PhD, I trained in theoretical cognitive psychology and the development of cognitive paradigms of attention including eye-tracking methodology. I am currently working under the supervision of Dr. Diane Gilbert-Diamond to create eye-tracking protocols to investigate the role of attention and media multi-tasking on food cue reactivity in children, an important predictor of childhood obesity. Additionally, Dr. Gilbert-Diamond and I are working with Dr. James Sargent to use eye-tracking methodology to investigate the association between exposure to electronic-cigarette ads and adolescent smoking initiation, an association that may have important policy implications for the FDA.<\/p>\n<\/div><\/div>

<\/div>

\"man<\/p>

Reed Bratches, PhD (Affiliated Trainee)<\/h3>\n

PhD, The Dartmouth Institute for Health Policy & Clinical Practice, 2022<\/p>\n

Research interests<\/b>
\nDr. Reed Bratches received his PhD from The Dartmouth Institute for Health Policy & Clinical Practice at the Geisel School of Medicine at Dartmouth. There, his research interests primarily involved the use of mixed methods to inform the development of interventions to support the informational needs of family caregivers from clinic visits. He has experience with the design and conduct of systematic reviews and meta analyses, surveys, and clinical trials. Dr. Bratches is currently a T32 Postdoctoral Fellow at the University of Alabama at Birmingham in the Center for Outcomes and Effectiveness Research and Education.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Marissa Clark, BS<\/h3>\n

Marissa Clark completed her Masters Degree in the context of the Psychological and Brain Sciences Ph.D. program after working under the supervision of Dr. Luke Chang. Broadly, she focused on understanding how the brain processes emotion. The goal of her primary project was to develop and validate robust, generalizable brain representations linked to multiple varieties of emotional experience, and analyze the structure of those brain representations to characterize the underlying dimensionality and organizational principles. The aim was to use these data to deliver brain and psychological interventions expected to influence emotion by changing target brain patterns. Marissa left the PhD program after completing her Masters requirements to begin a position as a Data Scientist applying data science and machine learning to problem solve consumer issues.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Amanda Collins, PhD<\/h3>\n

PhD in Clinical Psychology from Mississippi State University, 2023<\/p>\n

Research interests<\/strong>
\nDr.\u00a0Amanda<\/span>\u00a0Collins is a Member of the Faculty at Massachusetts General Hospital and Harvard Medical School, with a primary appointment in the Department of Psychiatry and Depression Clinical and Research Program. She completed her T32 Postdoctoral Research Fellow at Dartmouth College and the Center for Technology and Behavioral Health with Dr. Nick Jacobson, and she received her PhD in clinical psychology from Mississippi State University under the mentorship of E. Samuel Winer. Her research focuses on reward dysfunction as a transdiagnostic mechanism underlying the etiology and maintenance of psychopathology, including depression, anxiety, and substance use disorders. The two areas of her research focus on: (1) the application of advanced statistical methods to predict changes in psychopathology and (2) the development and testing of both in-person and digital interventions. She is particularly interested in bridging these two areas of research by using advanced methods to understand what interventions work best and for whom, with the overall goal of developing more personalized interventions to treat reward dysfunction transdiagnostically. Dr. Collins utilizes a multimodal approach, including self-reports, experimental paradigms, ecological momentary assessments, and passive sensing, to investigate the dynamic and heterogeneous nature of psychopathology. She also has extensive experience with longitudinal data analysis, including multilevel and time-varying vector autoregressive modeling, mixed-effects modeling, and machine learning to investigate how reward dysfunction changes over time and influences the course, severity, and treatment of psychopathology. Her work has been funded by the National Institute on Drug Abuse to develop and evaluate digital interventions for co-occurring disorders.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Alex daSilva, PhD<\/h3>\n

PhD in Psychological and Brain Sciences, Dartmouth College, 2021<\/p>\n

Research interests<\/b>
\nI completed my PhD at Dartmouth College with Dr. Meghan Meyer in the Dartmouth Social Neuroscience Lab. Broadly, my research centers around using passively collected data from smartphones to better understand aspects of mental health. Of particular interest is using conversation detected from smartphones as a proxy for social behavior to see how mental health impacts real-world social interactions. I am currently working as a Quantitative Scientist with Merck.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Danielle Fournier, PhD<\/h3>\n

PhD, in Experimental and Molecular Medicine (Neuroscience), Dartmouth College, 2021<\/p>\n

Research interests<\/b>
\nThe focus of my dissertation research was on the neurobiology of learning and memory, which includes how different memory systems impact acquisition, consolidation, and retrieval of memory. I am now a Post-Doctoral Scholar in the Todd Lab in the Department of Psychological and Brain Sciences at Dartmouth College. I am continuing an investigation into the role of the retrosplenial cortex in cross-modal (e.g. auditory & visual cues) integration, which has implications for disorders involving sensory processing abnormalities (e.g. schizophrenia & autism spectrum disorder). Previous research has motivated my work in understanding how the retrosplenial cortex impacts persistent and strong fear memories involving specific environments (\"contexts\") and\/or cues using different associative learning paradigms. This research relates to work being done on post-traumatic stress disorder which involves the generalization of fear responses to otherwise neutral contexts or stimuli.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Joy Gabrielli, PhD<\/h3>\n

PhD in Experimental Psychology, University of Arkansas, 2016<\/p>\n

Research interests<\/strong>
\nSince my T32 training at Dartmouth, I have accepted a position as Assistant Professor in the Clinical and Health Psychology Department at the University of Florida (UF). In this role, I have established the Youth Risk and Resilience Lab, where I engage in research on prevention of and intervention for adolescent health risk behaviors. At UF, I also mentor graduate students training in clinical child psychology, run the outpatient Adolescent Mental Health Clinic, and remain active in areas of research I initiated during my training through the T32 program.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Angela M. Henricks, PhD<\/h3>\n

PhD in Experimental Psychology, Washington State University, 2016<\/p>\n

Research interests<\/b>
\nUsing a wide range of pharmacological, behavioral, and neurobiological techniques, my research career has continually focused on understanding the neural mechanism that underlie substance use and mental illness, with a special focus on sex differences. After my post-doctoral training at Dartmouth, I accepted a tenure-track assistant professor position in the Department of Psychology at Washington State University. As a faculty member, I am building my research program based on data collected while a T32 trainee at Dartmouth, while also mentoring graduate students and teaching both undergraduate and graduate courses.<\/p>\n<\/div><\/div>

<\/div>

\"man<\/p>

Jibran Khokhar, PhD (Affiliated Trainee)<\/h3>\n

PhD in Social and Health Psychology, North Dakota State University, 2020<\/p>\n

Research interests<\/b>
\nDr. Jibran Khokhar<\/a>\u00a0is an associate professor at the University of Toronto. Dr. Khokhar\u2019s research aims to understand the mechanisms underlying co-occurring serious mental illness and substance use disorders, using a variety of behavioural, pharmacological and translational neuroimaging techniques. In addition, his research interests also include assessing the long-term effects of adolescent drug (e.g., cannabis) use, and how these effects might contribute to the risk for serious mental illness and addiction. Lastly, Dr. Khokhar is also very interested in profiling the pharmacokinetic parameters related to different routes of exposure to drugs like nicotine and cannabis, as well as the impact of development and sex on these profiles.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Robert Klein, PhD<\/h3>\n

PhD in Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, 2012<\/p>\n

Research interests<\/b>
\nI was a NIH T-32 postdoctoral fellow at the Center for Technology and Behavioral Health (CTBH). I have a background in wilderness therapy leadership, and recently received my PhD in Social and Health Psychology from North Dakota State University. I trained under Dr. Michael Robinson and, thus far, my work has focused on affect, emotion reactivity, cognition, and experiential acceptance. I have 1) piloted new high-resolution measures of emotion reactivity designed to reveal the temporal signatures of maladaptive emotion generation systems, and 2) examined the links between traditional Buddhist teachings, acceptance, and emotion reactivity. At the CTBH, I was mentored by Dr. Nicholas Jacobson and planned to focus on more applied research targeting co-occurring disorders. I am interested in leveraging technology to investigate the intersection of cognition, emotion reactivity, and substance abuse disorders. After CTBH, I plan to transition to industry and work within the digital well-being intervention space. In my free time, I have cycled across two continents, enjoy traveling, building canoes, canoe-camping, ping-pong, and I am slightly obsessed with French cooking techniques.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Ashley Knapp, PhD<\/h3>\n

PhD in Experimental Psychology, University of Arkansas, 2016<\/p>\n

Research interests<\/b>
\nI am a Research Assistant Professor within the Feinberg School of Medicine at Northwestern University. My research interests involve leveraging emerging technologies to study the vulnerability of anxiety and related psychopathology in adolescents and to develop and evaluate effective prevention programs designed to reduce the incidence of anxiety and related disorders. I was recently awarded a NIMH-funded K01 award focused on digital mental health, with emphasis on harnessing digital tools to extend preventive interventions to underserved youth in community settings. I received my PhD in experimental psychology from the University of Arkansas (2016), where I was awarded a NIMH-funded F31 to develop and evaluate a brief anxiety \u201cpreintervention\u201d for at-risk youth. I went on to complete postdoctoral fellowships at the Center for Technology and Behavioral Health at Dartmouth College (2018) and at the Center for Behavioral Intervention Technologies at Northwestern University (2019).<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Amy Lansing, PhD (Affiliated Trainee)<\/h3>\n

PhD in Clinical Psychology, Department of Psychology, University of Utah, 2015<\/p>\n

Research interests<\/b>
\nDr. Hughes Lansing is a pediatric (child clinical health) psychologist and a tenure track assistant professor at the University of Vermont. Her primary research interest is in examining complex biosocial systems underlying daily health behaviors in youths and families and translating that knowledge into highly scalable and pragmatic digital health interventions. She adopts an interdisciplinary and micro-analytic approach to investigating biobehavioral and social mechanisms that undergird health behavior regulation in the daily life of youths with chronic health conditions and youths at risk for substance abuse. Dr. Hughes Lansing\u2019s research uses advanced technologies and methods to examine and intervene in daily health behaviors including: mobile sensing, intensive longitudinal modeling, neuroimaging, and technology-delivered interventions. Outside of the lab, Dr. Hughes Lansing enjoys exploring the outdoors, hiking, camping, and skiing throughout the seasons.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Dustin Lee, PhD<\/h3>\n

PhD, University of Kentucky, 2013<\/p>\n

Research interests<\/b>
\nI am currently an Assistant Professor at the Behavioral Pharmacology Research Unit in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University. My current research focuses on better understanding the behavioral pharmacology of and treatments for tobacco and cannabis use disorders. I currently have NIDA-funded studies evaluating cannabidiol for tobacco use disorder, and examining the impact of cannabis tolerance on laboratory and roadside measurements of cannabis impairment.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Shea Lemley, PhD<\/h3>\n

PhD in Behavioral Psychology, University of Kansas, 2018<\/p>\n

Research interests<\/b>
\nAfter completing my T32 training at Dartmouth, I accepted a National Science Foundation Innovative Postdoctoral Entrepreneurial Research Fellowship (I-PERF). In this role, I am working with a start-up company that is developing technology to optimize behavioral therapy. In this role, I provide subject matter expertise on methods, analyses, and clinical procedures to improve products and services.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Daniel M. Mackin, PhD (Affiliated Trainee)<\/h3>\n

PhD in Clinical Psychology from Stony Brook University, 2023<\/p>\n

Research interests<\/strong>
\nDr. Daniel M. Mackin is an Assistant Professor and Licensed Clinical Psychologist in the Department of Psychiatry at Dartmouth Hitchcock Medical Center. He earned his PhD in Clinical Psychology from Stony Brook University in 2023 and completed a postdoctoral fellowship at Dartmouth supervised by Dr. Nicholas Jacobson in 2024. Broadly, Dr. Mackin is interested in digital mental health, especially using technology to improve our assessment and treatment of mood disorders. Under the mentorship of Dr. Nick Jacobson, Dr. Mackin used data passively collected by smartphones and wearable devices, such as movement and geolocation, to predict and characterize depression and anxiety. In his spare time, he enjoys golfing, woodworking, and spending time with his family and dogs.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Travis Masterson, PhD<\/h3>\n

PhD in Nutritional Sciences, The Pennsylvania State University, 2018
\nMS in Exercise Sciences \u2013 Health Promotion, Brigham Young University, 2015
\nBS in Exercise and Wellness, Brigham Young University, 2013<\/p>\n

Research interests<\/b>
\nI am currently an assistant professor in the Nutritional Sciences Department at The Pennsylvania State University and Director of the Health, Ingestive Behavior, and Technology Laboratory. My research focuses on the impact of technology on health and using technology to improve health outcomes such as food intake and weight. Specifically, I am currently working to understand the impact of livestreaming on platforms such as Twitch and YouTube and the associated marketing practices on eating behaviors. I am also leveraging technology such as virtual reality (VR), smartphones, and fMRI to better understand eating behavior and provide tools for those interested in improving their eating behaviors.<\/p>\n

Contact Information<\/b>
\ntpm5262@psu.edu<\/a><\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Matthew Nemesure, PhD<\/h3>\n

PhD in Quantitative Biomedical Sciences, Geisel School of Medicine at Dartmouth College, 2023<\/p>\n

Research interests<\/strong>
\nDr. Matthew Nemesure received his PhD in Quantitative Biomedical Sciences through the Geisel School of Medicine at Dartmouth. His research interests primarily involved the use of machine learning and statistical tools to assist in understanding, diagnosing and treating substance use and mental health disorders. Specifically, he was involved in developing tools to both help with digital intervention allocation for Major Depression Disorder (MDD) as well as understand how MDD dynamics change over time, leading to the development and deployment of just-in-time interventions. This model of care would be able to adapt the content and delivery of a digital intervention based on a person\u2019s symptoms and needs at a given point in time. Additionally, Dr. Nemesure applied innovative statistical and data science methods in other areas of mental health to make meaningful change. Examples of this work include models to better understand psychotic-like events in cannabis users, models to predict suicidal ideation and completed suicide in an epilepsy clinic, models to better describe the day-to-day experience of anxiety and treatment allocation models in mental health disorders outside of MDD. Dr. Nemesure is currently a Senior Data Scientist - Natural Language Processing at the D^3 Institute at Harvard.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Tonychris Nnaka, PhD<\/h3>\n

PhD in Clinical Psychology, University of Texas at Austin School of Nursing, 2022<\/p>\n

Research interests<\/b>
\nDr. Nnaka earned his PhD from the University of Texas at Austin School of Nursing under the NIH-funded T32 Precision Health Intervention Methodology Training in Self-Management of Multiple Chronic Conditions. He is a health disparities and heart disease researcher, with a primary research interest in the use of digitized intervention approach to promote adherence to self-management behaviors among patients with heart diseases. As a research fellow at Dartmouth College, Dr. Nnaka was mentored by Dr. Catherine Stanger and worked with her in delivering a digital health clinical trial intervention for type 1 diabetes management targeting young adults. Dr. Nnaka joined the University of Texas Health Science Center College of Nursing in Fort Worth, Texas as a tenure-track associate professor.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Elizabeth Saunders, PhD<\/h3>\n

PhD, The Dartmouth Institute for Health Policy & Clinical Practice, 2020<\/p>\n

Research interests<\/b>
\nAfter completing my T32 training at Dartmouth in January of 2021, I accepted a Senior Scientist position at Advocates for Human Potential, Inc., where I now conduct research and provide consulting to better understand, prevent, and treat Substance Use Disorders. Currently, my work is focused on addressing opioid misuse, examining public health implications of cannabis legalization, and investigating strategies to mitigate harm associated with problematic or risky cannabis use. After earning my PhD in the summer of 2018, I began working with Dr. Alan Budney to leverage behavioral economic methods to better understand the factors that underlie and maintain cannabis misuse. I also collaborated with multiple Dartmouth colleagues on projects that sought to identify risky patterns of cannabis use, and I continue to do so today.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Michael Sofis, PhD<\/h3>\n

PhD in Behavioral Psychology, University of Kansas, 2018<\/p>\n

Research interests<\/b>
\nAfter completing my T32 training at Dartmouth in January of 2021, I accepted a Senior Scientist position at Advocates for Human Potential, Inc., where I now conduct research and provide consulting to better understand, prevent, and treat Substance Use Disorders. Currently, my work is focused on addressing opioid misuse, examining public health implications of cannabis legalization, and investigating strategies to mitigate harm associated with problematic or risky cannabis use. After earning my PhD in the summer of 2018, I began working with Dr. Alan Budney to leverage behavioral economic methods to better understand the factors that underlie and maintain cannabis misuse. I also collaborated with multiple Dartmouth colleagues on projects that sought to identify risky patterns of cannabis use, and I continue to do so today.<\/p>\n<\/div><\/div>

<\/div>

\"woman<\/p>

Cara Struble, PhD<\/h3>\n

PhD in Clinical Psychology, Wayne State University, 2021<\/p>\n

Research interests<\/b>
\nDr. Cara A. Struble earned her PhD in Clinical Psychology from Wayne State University in 2021, where she specialized in the assessment and treatment of substance use and co-occurring disorders. Dr. Struble is particularly interested in understanding cannabis use risks, behaviors, and consequences within LGBTQ+ populations. Under the primary mentorship of Dr. Alan Budney, Dr. Struble is developing a program of research investigating scalable digital technologies, adapted for LGBTQ+ populations, to improve access to evidence-based treatments for cannabis and co-occurring mental health problems. She has recently completed an internally funded pilot study aimed at recruiting and engaging LGBTQ+ cannabis consumers in research to assess interest in a mobile health intervention for cannabis and co-occurring mental health problems. Dr. Struble is also working towards becoming a Licensed Clinical Psychologist. In her spare time, Dr. Struble enjoys baking, hiking, and attending drag performances.<\/p>\n<\/div><\/div>

<\/div>

\"\"<\/p>

Diana Wallin, PhD<\/h3>\n

PhD in Neuroscience, University of Minnesota, 2017
\nBS in Physics, Massachusetts Institute of Technology, 2007<\/p>\n

Research interests<\/b>
\nMy research interests and career path have led to my growing interest in the study of co-occurring disorders. As a graduate student I studied the effects of phlebotomy-induced anemia on brain neurochemistry, both acutely and long-term, using magnetic resonance spectroscopy. This work in early brain development and neuroimaging and has led to my current interest in disentangling the relative contributions of known neurodevelopmental insults that lead to a predisposition for patients with schizophrenia to develop a co-occurring substance use disorder. Under the mentorship of Dr. Wilder Doucette, I am currently studying the connectivity within the brain\u2019s reward circuit using a rat model of schizophrenia created by lesioning the brain during early-life. We hope this model will lead to validation of reward circuit connectivity as a biomarker to further study co-occurring substance use disorders in schizophrenia.<\/p>\n<\/div><\/div>

<\/div>
<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71","page","type-page","status-publish","hentry","author-9"],"_links":{"self":[{"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/pages\/71","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/comments?post=71"}],"version-history":[{"count":6,"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/pages\/71\/revisions"}],"predecessor-version":[{"id":243,"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/pages\/71\/revisions\/243"}],"wp:attachment":[{"href":"https:\/\/geiselmed.dartmouth.edu\/scd\/wp-json\/wp\/v2\/media?parent=71"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}